Pharmanovia, a global pharmaceutical company, expanded its neurology portfolio with the acquisition of 11 central nervous system (CNS) brands from Sanofi. The brands span four therapy areas associated with CNS disorders: psycholeptic, anxiolytic, anti-epileptic, and anti-psychotic. Clobazam is from a class of drug called benzodiazepines and can be used to treat anxiety, with or without insomnia or certain psychiatric conditions. The acquired brands include Frisium, Sentil, Urbanyl, Urbanil...